Arimidex (Anastrozole) Research in Pennsylvania | QSC

Arimidex (Anastrozole) Research — Pennsylvania

Arimidex (Anastrozole) is a Non-steroidal aromatase inhibitor (AI) used in research models studying Aromatase Inhibition Research, ER-Positive Breast Cancer Research, Oestrogen Control in Androgen Research. QSC supplies Arimidex to research institutions, university laboratories, and independent researchers across Pennsylvania with domestic USA shipping and third-party Janoshik COA verification.

About Arimidex (Anastrozole)

Anastrozole is a potent, selective, non-steroidal aromatase inhibitor (AI). Reversibly inhibits the CYP19A1 (aromatase) enzyme which converts androgens (testosterone, androstenedione) to oestrogens (oestradiol, oestrone) in peripheral adipose tissue, adrenal glands, and breast tissue. At 1mg/day suppresses oestradiol >80% in postmenopausal women. Used in research to control oestrogen elevation dur…

Full mechanistic overview and research data: Arimidex Research Hub →

QSC Shipping to Pennsylvania

QSC operates a domestic USA fulfilment network with 5-region shipping coverage. Orders to Pennsylvania ship from the nearest domestic hub — typically 3–5 business days. All compounds ship in sealed, temperature-appropriate, discrete packaging with Janoshik COA documentation.